an overview of the birch trial investigating atezolizumab in nsclc
Published 7 years ago • 91 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
1:10
the birch trial data discussed by dr peters
-
4:00
birch: phase 2 trial of atezolizumab for advanced pd-l1-selected non-small cell lung cancer
-
3:15
atezolizumab’s role in treating nondriver nsclc
-
3:07
neoadjuvant atezolizumab in nsclc
-
1:48
results of keynote-024 trial of pembrolizumab in nsclc
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
3:01
choosing between atezolizumab and pembrolizumab in lung cancer
-
2:44
disease-free survival in impower010 trial: adjuvant atezolizumab in nsclc
-
6:33
a win for small–cell lung cancer: impower 133
-
7:48
considerations in the management of alk nsclc
-
1:30
canopy-a: canakinumab for resected nsclc
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
1:41
adjuvant atezolizumab in nsclc
-
1:30
atezolizumab and bevacizumab studied in patients with metastatic rcc
-
3:08
stage 3 unresectable nsclc: the pacific trial
-
1:19
the investigation of immune checkpoint blockades in small cell lung cancer
-
8:07
quadruplet therapy in nsclc: impower150
-
2:03
t-cell dynamics in response to neoadjuvant atezolizumab in early nsclc